Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Dec 4;214(12):3477-3479.
doi: 10.1084/jem.20172045. Epub 2017 Nov 21.

A role for astroglia in prion diseases

Affiliations
Comment

A role for astroglia in prion diseases

Adriano Aguzzi et al. J Exp Med. .

Abstract

In this issue of JEM, Krejciova et al. (https://doi.org/10.1084/jem.20161547) report that astrocytes derived from human iPSCs can replicate human CJD prions. These observations provide a new, potentially very valuable model for studying human prions in cellula and for identifying antiprion compounds that might serve as clinical candidates. Furthermore, they add to the evidence that astrocytes may not be just innocent bystanders in prion diseases.

PubMed Disclaimer

Figures

None
Insight from Adriano Aguzzi and Yingjun Liu
None
(a) Human iPSC-derived astrocyte supports the replication of CJD prions. In contrast to differentiated astrocytes, however, human iPSC-derived APCs failed to replicate human prions despite expression of PrPC. It is still unclear whether human iPSC-derived neurons, oligodendrocytes, and their precursors (NPC and OPC, respectively) are capable of supporting human prion replication. (b) Rodent studies have showed that differentiated neurons and astrocytes, but neither undifferentiated neurospheres nor oligodendrocytes, support prion replication.

Comment on

References

    1. Aguzzi A., et al. Annu. Rev. Pathol. 2008 doi: 10.1146/annurev.pathmechdis.3.121806.154326. - DOI - PubMed
    1. Aguzzi A., et al. Annu. Rev. Pharmacol. Toxicol. 2017 doi: 10.1146/annurev-pharmtox-010617-052745. - DOI - PubMed
    1. Aguzzi A., and Polymenidou M. Cell. 2004 doi: 10.1016/S0092-8674(03)01031-6. - DOI - PubMed
    1. Bolognesi M.L., and Legname G. Expert Opin. Drug Discov. 2015 doi: 10.1517/17460441.2015.1016498. - DOI - PubMed
    1. Büeler H., et al. Cell. 1993 doi: 10.1016/0092-8674(93)90360-3. - DOI